SOLV Stock Overview
A healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 1/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Solventum Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$70.81 |
| 52 Week High | US$96.05 |
| 52 Week Low | US$47.16 |
| Beta | 0 |
| 11 Month Change | -2.33% |
| 3 Month Change | 15.33% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -11.49% |
Recent News & Updates
Recent updates
A Look At The Intrinsic Value Of Solventum Corporation (NYSE:SOLV)
Oct 10
Solventum: No Rush To Buy As Post-Spin Execution Will Take Time To Play Out
Sep 11Solventum (NYSE:SOLV) Has A Pretty Healthy Balance Sheet
Aug 18Solventum: Stumbling Out Of The Gate
Jul 07Solventum Corporation (NYSE:SOLV) Shares Could Be 27% Below Their Intrinsic Value Estimate
Jun 26Solventum: A Reasonable Start, Still Some Questions To Be Asked
May 173M Says Bye To Solventum - Why I Stick To My Bullish Call
Apr 02Shareholder Returns
| SOLV | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 4.9% | 1.5% | 2.2% |
| 1Y | n/a | 20.9% | 31.7% |
Return vs Industry: Insufficient data to determine how SOLV performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how SOLV performed against the US Market.
Price Volatility
| SOLV volatility | |
|---|---|
| SOLV Average Weekly Movement | 3.7% |
| Medical Equipment Industry Average Movement | 8.1% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: SOLV has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: SOLV's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2023 | 22,000 | Bryan Hanson | www.solventum.com |
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes.
Solventum Corporation Fundamentals Summary
| SOLV fundamental statistics | |
|---|---|
| Market cap | US$12.03b |
| Earnings (TTM) | US$720.00m |
| Revenue (TTM) | US$8.22b |
17.0x
P/E Ratio1.5x
P/S RatioIs SOLV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SOLV income statement (TTM) | |
|---|---|
| Revenue | US$8.22b |
| Cost of Revenue | US$3.58b |
| Gross Profit | US$4.63b |
| Other Expenses | US$3.91b |
| Earnings | US$720.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.17 |
| Gross Margin | 56.38% |
| Net Profit Margin | 8.76% |
| Debt/Equity Ratio | 254.0% |
How did SOLV perform over the long term?
See historical performance and comparison